Company · CIK 2036042
Sionna Therapeutics, Inc.
| CIK | 2036042 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | SION (Nasdaq) |
| First annual or quarterly report | 2025-03-20 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-293909 | 2026-03-02 | 2026-03-02 | 1 | |
| 333-284352 | 2025-01-17 | 2025-02-07 | 4 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-02 | S-3ASRShelf registered | 333-293909 | 0001193125-26-084308 |
| 2025-02-07 | 424B4Final prospectus | 333-284352 | 0001193125-25-022709 |
| 2025-02-06 | EFFECTDeclared effective | 333-284352 | 9999999995-25-000339 |
| 2025-02-03 | S-1/AAmendment | 333-284352 | 0001193125-25-018825 |
| 2025-01-17 | S-1Registration filed | 333-284352 | 0001193125-25-008474 |
| 2024-09-12 | DRSDraft made public | 377-07436 | 0000950123-24-009204 |